DAA-Based Treatment for HIV–HCV-Coinfected Patients: Analysis of Factors of Sustained Virological Response in a Real-Life Study
Loredana Alessio(Ospedale Sant'Anna), Nicola Coppola(University of Campania "Luigi Vanvitelli"), Viviana Rizzo(Ospedale D. Cotugno), Matteo Megna(University of Padua), Elio Manzillo(Ospedale Monaldi), Maurizio D’Abbraccio(Ospedale D. Cotugno), Vincenzo Sangiovanni(Ospedale Sant'Anna), Filomena Simeone(Ospedale Sant'Anna), L. Aprea(Ospedale D. Cotugno), Giovanni Di Filippo(Federico II University Hospital), Lorenzo Onorato(University of Campania "Luigi Vanvitelli"), Salvatore Martini(University of Campania "Luigi Vanvitelli"), Annalisa Saracino(University of Bari Aldo Moro), Vincenzo Esposito(International Society for Computational Biology), Sebastiano Leone, Eugenio Milano(University of Bari Aldo Moro), Francesco Borrelli(Federico II University Hospital), Nicolina Capoluongo(University of Campania "Luigi Vanvitelli")
Cited by 7
Related Papers
Ceftazidime-Avibactam Use for Klebsiella pneumoniae Carbapenemase–Producing <i>K. pneumoniae</i> Infections: A Retrospective Observational Multicenter Study
|Clinical Infectious Diseases|2021|264
Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)
|Clinical Infectious Diseases|2023|156
Cardiovascular risk and dyslipidemia among persons living with HIV: a review
|BMC Infectious Diseases|2017|152
Negative impact of hyperglycaemia on tocilizumab therapy in Covid-19 patients
|Diabetes & Metabolism|2020|138
Incidence of long COVID-19 in people with previous SARS-Cov2 infection: a systematic review and meta-analysis of 120,970 patients
|Internal and Emergency Medicine|2022|113